Original
Discontinuación y adherencia a largo plazo en la terapia con interferón beta en pacientes con esclerosis múltiple
Discontinuation and long-term adherence to beta interferon therapy in patients with multiple sclerosis
Leído
6302
Vecesse ha leído el artículo
1436
Total PDF
4866
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 50 | 9 | 59 |
| 2025 5 | 84 | 24 | 108 |
| 2025 4 | 80 | 16 | 96 |
| 2025 3 | 60 | 19 | 79 |
| 2025 2 | 46 | 18 | 64 |
| 2025 1 | 41 | 28 | 69 |
| 2024 12 | 37 | 16 | 53 |
| 2024 11 | 40 | 20 | 60 |
| 2024 10 | 23 | 18 | 41 |
| 2024 9 | 35 | 19 | 54 |
| 2024 8 | 43 | 17 | 60 |
| 2024 7 | 26 | 20 | 46 |
| 2024 6 | 46 | 18 | 64 |
| 2024 5 | 49 | 17 | 66 |
| 2024 4 | 28 | 19 | 47 |
| 2024 3 | 30 | 7 | 37 |
| 2024 2 | 32 | 17 | 49 |
| 2024 1 | 35 | 25 | 60 |
| 2023 12 | 32 | 13 | 45 |
| 2023 11 | 43 | 23 | 66 |
| 2023 10 | 36 | 15 | 51 |
| 2023 9 | 31 | 27 | 58 |
| 2023 8 | 27 | 6 | 33 |
| 2023 7 | 37 | 14 | 51 |
| 2023 6 | 30 | 18 | 48 |
| 2023 5 | 48 | 20 | 68 |
| 2023 4 | 55 | 15 | 70 |
| 2023 3 | 32 | 13 | 45 |
| 2023 2 | 33 | 14 | 47 |
| 2022 1 | 60 | 9 | 69 |
| 2022 12 | 29 | 5 | 34 |
| 2022 11 | 54 | 6 | 60 |
| 2022 10 | 34 | 11 | 45 |
| 2022 9 | 34 | 16 | 50 |
| 2022 8 | 44 | 10 | 54 |
| 2022 7 | 21 | 8 | 29 |
| 2022 6 | 23 | 6 | 29 |
| 2022 5 | 24 | 13 | 37 |
| 2022 4 | 25 | 8 | 33 |
| 2022 3 | 51 | 11 | 62 |
| 2022 2 | 43 | 2 | 45 |
| 2021 1 | 79 | 6 | 85 |
| 2021 12 | 28 | 10 | 38 |
| 2021 11 | 31 | 9 | 40 |
| 2021 10 | 44 | 10 | 54 |
| 2021 9 | 32 | 8 | 40 |
| 2021 8 | 22 | 6 | 28 |
| 2021 7 | 27 | 9 | 36 |
| 2021 6 | 25 | 10 | 35 |
| 2021 5 | 26 | 11 | 37 |
| 2021 4 | 56 | 11 | 67 |
| 2021 3 | 40 | 13 | 53 |
| 2021 2 | 24 | 6 | 30 |
| 2020 1 | 30 | 9 | 39 |
| 2020 12 | 33 | 7 | 40 |
| 2020 11 | 17 | 5 | 22 |
| 2020 10 | 14 | 9 | 23 |
| 2020 9 | 19 | 13 | 32 |
| 2020 8 | 24 | 2 | 26 |
| 2020 7 | 10 | 9 | 19 |
| 2020 6 | 11 | 2 | 13 |
| 2020 5 | 21 | 7 | 28 |
| 2020 4 | 18 | 5 | 23 |
| 2020 3 | 24 | 10 | 34 |
| 2020 2 | 17 | 9 | 26 |
| 2020 1 | 12 | 4 | 16 |
| 2019 12 | 14 | 15 | 29 |
| 2019 11 | 12 | 4 | 16 |
| 2019 10 | 26 | 10 | 36 |
| 2019 9 | 30 | 2 | 32 |
| 2019 8 | 16 | 9 | 25 |
| 2019 7 | 15 | 7 | 22 |
| 2019 6 | 25 | 19 | 44 |
| 2019 5 | 74 | 18 | 92 |
| 2019 4 | 34 | 18 | 52 |
| 2019 3 | 6 | 12 | 18 |
| 2019 2 | 10 | 3 | 13 |
| 2019 1 | 9 | 5 | 14 |
| 2018 12 | 8 | 5 | 13 |
| 2018 11 | 19 | 10 | 29 |
| 2018 10 | 44 | 22 | 66 |
| 2018 9 | 16 | 6 | 22 |
| 2018 8 | 10 | 5 | 15 |
| 2018 7 | 12 | 7 | 19 |
| 2018 6 | 8 | 2 | 10 |
| 2018 5 | 13 | 8 | 21 |
| 2018 4 | 21 | 2 | 23 |
| 2018 3 | 15 | 2 | 17 |
| 2018 2 | 17 | 1 | 18 |
| 2018 1 | 10 | 3 | 13 |
| 2017 12 | 11 | 1 | 12 |
| 2017 11 | 9 | 3 | 12 |
| 2017 10 | 15 | 4 | 19 |
| 2017 9 | 17 | 3 | 20 |
| 2017 8 | 8 | 1 | 9 |
| 2017 7 | 10 | 0 | 10 |
| 2017 6 | 21 | 3 | 24 |
| 2017 5 | 25 | 5 | 30 |
| 2017 4 | 12 | 5 | 17 |
| 2017 3 | 18 | 16 | 34 |
| 2017 2 | 15 | 5 | 20 |
| 2016 1 | 29 | 3 | 32 |
| 2016 12 | 44 | 8 | 52 |
| 2016 11 | 49 | 9 | 58 |
| 2016 10 | 56 | 14 | 70 |
| 2016 9 | 32 | 10 | 42 |
| 2016 8 | 31 | 10 | 41 |
| 2016 7 | 35 | 6 | 41 |
| 2016 6 | 40 | 31 | 71 |
| 2016 5 | 41 | 25 | 66 |
| 2016 4 | 26 | 17 | 43 |
| 2016 3 | 19 | 20 | 39 |
| 2016 2 | 21 | 14 | 35 |
| 2015 1 | 24 | 19 | 43 |
| 2015 12 | 30 | 13 | 43 |
| 2015 11 | 26 | 13 | 39 |
| 2015 10 | 28 | 12 | 40 |
| 2015 9 | 27 | 16 | 43 |
| 2015 8 | 18 | 10 | 28 |
| 2015 7 | 17 | 8 | 25 |
| 2015 6 | 12 | 4 | 16 |
| 2015 5 | 21 | 8 | 29 |
| 2015 4 | 22 | 8 | 30 |
| 2015 3 | 26 | 8 | 34 |
| 2015 2 | 39 | 6 | 45 |
| 2015 1 | 34 | 10 | 44 |
| 2014 12 | 43 | 7 | 50 |
| 2014 11 | 29 | 4 | 33 |
| 2014 10 | 36 | 6 | 42 |
| 2014 9 | 31 | 4 | 35 |
| 2014 8 | 32 | 6 | 38 |
| 2014 7 | 44 | 4 | 48 |
| 2014 6 | 32 | 4 | 36 |
| 2014 5 | 39 | 4 | 43 |
| 2014 4 | 31 | 3 | 34 |
| 2014 3 | 20 | 5 | 25 |
| 2014 2 | 21 | 3 | 24 |
| 2014 1 | 35 | 3 | 38 |
| 2013 12 | 25 | 5 | 30 |
| 2013 11 | 28 | 7 | 35 |
| 2013 10 | 48 | 6 | 54 |
| 2013 9 | 26 | 4 | 30 |
| 2013 8 | 37 | 5 | 42 |
| 2013 7 | 27 | 3 | 30 |
| 2012 3 | 595 | 0 | 595 |
Mostrar todo
